viewBushveld Minerals Ltd

Bushveld takes 8.71% in new vanadium financing partnership business, as RedT’s merger with Avalon completes

Bushveld Minerals is a leading player in vanadium production

Bushveld Minerals Ltd -

Bushveld Minerals Ltd (LON:BMN) (OTCMKTS:BSHVF) is to take an 8.71% interest in a newly-created entity called Invinity, created by the proposed merger of RedT Energy with Avalon Battery Corporation which has now received shareholder approval

The merger will create a leading player in the growing energy storage market with a presence in North America, Europe, sub-Saharan Africa and Asia.

In addition to the funding from Bushveld, Invinity has raised £7.9mln through an equity placing at 1.65p per share.

Bushveld revealed in November that it would support the merger in the form of a US$5mln convertible loan. That loan will now convert into just over 3mln shares.

Bushveld entered into a joint venture agreement with redT on 9 March 2020 to form a vanadium financing partnership to supply vanadium electrolyte to be used in third party-owned vanadium redox flow battery (VRFB) projects developed by redT. The joint venture agreement will be transferred to Invinity.

"At only a few months old, our VRFB Investment Platform is already gathering momentum on the back of the investments made to date,” said Fortune Mojapelo, chief executive Bushveld Minerals Limited in a statement.

"Invinity starts its journey with a strong project pipeline already in place, one which it plans to grow even more in the future. Despite the global impact of the Covid-19 (coronavirus) pandemic, the fundamental need for long duration energy storage to support the energy transition has not changed.

The benefit to Bushveld of supporting this downstream vanadium-based industry is already becoming clear, and Bushveld continues to support the growth and its participation in the energy storage industry," he added.

Quick facts: Bushveld Minerals Ltd

Price: 13.5 GBX

Market: LSE
Market Cap: £155.65 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Ltd named herein, including the promotion by the Company of Bushveld Minerals Ltd in any Content on the Site, the Company...



Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom.  Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as...

on 07/31/2019

2 min read